Prolonged inhibition of 5-HT3 receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization
Autor: | Hothersall, J Daniel, Moffat, Christopher, Connolly, Christopher N |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2013 |
Předmět: |
irreversible antagonism
Nystatin Quinuclidines Down-Regulation Granisetron Radioligand Assay Allosteric Regulation Chlorocebus aethiops endocytosis Animals Humans Serotonin 5-HT3 Receptor Antagonists palonosetron allosterism Cell Membrane Hydrazones emesis receptor trafficking Isoquinolines Research Papers Recombinant Proteins Kinetics Protein Transport 5-HT3 receptor COS Cells cancer therapy Antiemetics Receptors Serotonin 5-HT3 |
Zdroj: | British Journal of Pharmacology |
ISSN: | 1476-5381 0007-1188 |
Popis: | Background and Purpose The 5-HT3 receptor antagonist palonosetron is an important treatment for emesis and nausea during cancer therapy. Its clinical efficacy may result from its unique binding and clearance characteristics and receptor down-regulation mechanisms. We investigated the mechanisms by which palonosetron exerts its long-term inhibition of 5-HT3 receptors for a better understanding of its clinical efficacy. Experimental Approach Cell surface receptors (recombinantly expressed 5HT3A or 5HT3AB in COS-7 cells) were monitored using [3H]granisetron binding and ELISA after exposure to palonosetron. Receptor endocytosis was investigated using immunofluorescence microscopy. Key Results Chronic exposure to palonosetron reduced the number of available cell surface [3H]granisetron binding sites. This down-regulation was not sensitive to either low temperature or pharmacological inhibitors of endocytosis (dynasore or nystatin) suggesting that internalization did not play a role. This was corroborated by our observation that there was no change in cell surface 5-HT3 receptor levels or increase in endocytic rate. Palonosetron exhibited slow dissociation from the receptor over many hours, with a significant proportion of binding sites being occupied for at least 4 days. Furthermore, our observations suggest that chronic receptor down-regulation involved interactions with an allosteric binding site. Conclusions and Implications Palonosetron acts as a pseudo-irreversible antagonist causing prolonged inhibition of 5-HT3 receptors due to its very slow dissociation. In addition, an irreversible binding mode persists for at least 4 days. Allosteric receptor interactions appear to play a role in this phenomenon. |
Databáze: | OpenAIRE |
Externí odkaz: |